Applied Genetic Tech (AGTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 105,052 | 89,531 | 19,108 | 31,570 | 38,463 |
| Marketable Securities | 2,000 | 21,496 | 33,989 | 34,987 | 41,995 |
| Other current assets | 0 | 1,997 | 0 | 0 | 0 |
| TOTAL | $109,707 | $113,024 | $55,177 | $68,541 | $82,964 |
| Non-Current Assets | |||||
| PPE Net | 4,658 | 4,019 | 4,095 | 4,314 | 4,311 |
| Investments And Advances | 8,000 | 8,021 | 8,046 | 8,067 | 8,096 |
| Intangibles | 1,287 | 1,291 | 1,194 | 1,136 | 1,098 |
| Other Non-Current Assets | 3,314 | 3,311 | 3,457 | 3,557 | 3,850 |
| TOTAL | $17,259 | $16,642 | $16,792 | $17,074 | $17,355 |
| Total Assets | $126,966 | $129,666 | $71,969 | $85,615 | $100,319 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,181 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,879 | 1,926 | 1,775 | 1,654 | 1,355 |
| Accrued Expenses | 14,500 | 13,504 | 11,352 | 10,246 | 10,502 |
| TOTAL | $19,714 | $16,553 | $14,244 | $13,012 | $12,963 |
| Non-Current Liabilities | |||||
| Long Term Debt | 17,727 | 9,929 | 9,844 | 9,759 | 9,677 |
| Other Non-Current Liabilities | 3,717 | 6,184 | 6,346 | 6,616 | 6,625 |
| TOTAL | $21,444 | $16,113 | $16,203 | $16,401 | $16,340 |
| Total Liabilities | $41,158 | $32,666 | $30,447 | $29,413 | $29,303 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 42,860 | 42,755 | 42,658 | 25,890 | 25,858 |
| Common Shares | 43 | 42 | 25 | 25 | 25 |
| Retained earnings | -239,269 | -227,133 | -212,282 | -196,820 | -181,440 |
| Other shareholders' equity | -211 | -211 | -211 | -211 | -88 |
| TOTAL | $85,808 | $97,000 | $41,522 | $56,202 | $71,016 |
| Total Liabilities And Equity | $126,966 | $129,666 | $71,969 | $85,615 | $100,319 |